Plexus (PLXS) is higher today as the market continues to reward the company’s narrative of accelerating growth driven by new program ramps, share gains, and improving demand in its end markets. While there wasn’t a single, dominant new corporate headline identified for today, the move fits a continuation trade: investors are leaning into the most recent guidance framework and the visibility implied by the company’s manufacturing win activity and ramp commentary. (investor.plexus.com)

In its latest quarterly results release (fiscal Q1 2026, reported January 28, 2026), Plexus posted revenue of $1.070 billion and non-GAAP diluted EPS of $1.78, then guided fiscal Q2 revenue of $1.110 billion to $1.150 billion and non-GAAP EPS of $1.80 to $1.95. Management also pointed to 22 manufacturing program wins in the quarter, representing $283 million in annualized revenue when fully ramped—data points that can keep momentum bids active on up days even without fresh news. (investor.plexus.com)

The next key confirmation for the rally will be whether reported results and commentary show those program ramps translating into sustained sequential growth and margin durability, especially in higher-complexity end markets like Aerospace/Defense and Healthcare/Life Sciences. Traders will also watch for any incremental contract-win disclosures, updated outlook language, or changes in cadence of buybacks that could provide a cleaner day-of catalyst than a sentiment-driven continuation move. (investor.plexus.com)